State of the Art - How I manage coagulopathy in cardiac surgery patients

British Journal of Haematology

Volumn 164, Issue 6, 2014, Pages 779-789

  Davidson, Simon ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Coagulopathy

Indexed keywords

ACETYLSALICYLIC ACID; ACTIVATED PROTHROMBIN COMPLEX; ANTITHROMBIN; APIXABAN; APROTININ; ARGATROBAN; BLOOD CLOTTING FACTOR 10A INHIBITOR; BLOOD CLOTTING FACTOR 13 CONCENTRATE; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8 CONCENTRATE; BLOOD CLOTTING FACTOR 8 CRYOPRECIPITATE; BLOOD CLOTTING FACTOR 9 CONCENTRATE; CLOPIDOGREL; DABIGATRAN; FIBRINOGEN CONCENTRATE; FRESH FROZEN PLASMA; HAEMOCOMPLETTAN; HEPARIN; HIRULOG; PER 977; PLACEBO; PRASUGREL; PROTAMINE SULFATE; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RIVAROXABAN; TICAGRELOR; TRANEXAMIC ACID; UNCLASSIFIED DRUG; WARFARIN;

ACUTE KIDNEY FAILURE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD EXAMINATION; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL TRIAL (TOPIC); DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG FATALITY; HEART SURGERY; HEMODIALYSIS; HEMOSTASIS; HUMAN; LUNG EMBOLISM; MEDICAL DECISION MAKING; MORBIDITY; MULTICENTER STUDY (TOPIC); OFF LABEL DRUG USE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; THROMBOCYTE FUNCTION ANALYZER; THROMBOCYTE TRANSFUSION; THROMBOELASTOGRAPHY; THROMBOELASTOMETRY; TREATMENT OUTCOME; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

CARDIAC SURGERY; CARDIOPULMONARY BYPASS; COAGULOPATHY;

BLOOD COAGULATION DISORDERS; BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; HUMANS; POSTOPERATIVE HEMORRHAGE;

EID: 84896736766     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12746     Document Type: Review

References (67)

1. Andreasen, J.J. & Nielsen, C. (2004) Prophylactic tranexamic acid in elective primary coronary artery bypass surgery using cardiopulmonary bypass. European Journal of Cardiothoracic Surgery, 26, 311-317.
2. 3Arnékian, V., Camous, J., Fattal, S., Rézaiguia-Delclaux, S., Nottin, R. & Stéphan, F. (2012) Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery. Interactive Cardiovascular and Thoracic Surgery, 15, 382-389.
3. Aylsworth, C.L., Stefan, F., Woitas, K., Rieger, R.H., LeBoutillier, M. & DiSesa, V.J. (2004) New technology, old standards: disparate activated clotting time measurements by the Hemochron Jr compared with the standard Hemochron. Annals of Thoracic Surgery, 77, 973-976.
4. Bachmann, F., McKenna, R., Cole, E.R. & Najafi, H. (1975) The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. Journal of Thoracic and Cardiovascular Surgery, 70, 76-85.
5. Bennett-Guerrero, E., Song, H.K., Zhao, Y., Ferguson, Jr, T.B., Gammie, J.S., Peterson, E.D. & O'Brien, S.M. (2010) Temporal changes in the use of blood products for coronary artery bypass graft surgery in North America: an analysis of the Society of Thoracic Surgeons Adult Cardiac Database. Journal of Cardiothoracic and Vascular Anesthesia, 24, 814-816.
6. Bevan, D.H. (1999) Cardiac bypass haemostasis: putting blood through the mill. British Journal of Haematology, 104, 208-219.
7. Boisclair, M.D., Lane, D.A., Philippou, H., Sheikh, S. & Hunt, B. (1993a) Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment F1+2. Thrombosis and Haemostasis, 70, 253-258.
8. Boisclair, M.D., Lane, D.A., Philippou, H., Esnouf, M.P., Sheikh, S., Hunt, B. & Smith, K.J. (1993b) Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood, 82, 3350-3357.
9. Bolliger, D., Szlam, F., Molinaro, R.J., Rahe-Meyer, N., Levy, J.H. & Tanaka, K.A. (2009) Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model. British Journal of Anaesthesia, 102, 793-799.
10. Brenner, B. (1997) Fibrinolysis in Cardiac Surgery Management of bleeding after cardiac surgery. In: Landes Biosciences (ed. by R. Mohr, D. A. Goor & J. Lavee ), pp. 23-33. Landes Bioscience, Austin, TX.
11. Bruce, D. & Nokes, T.J. (2008) Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital. Critical Care, 12, R105.
12. Callum, J.L. & Rizoli, S. (2012) Assessment and management of massive bleeding: coagulation assessment, pharmacologic strategies, and transfusion management. Hematology/The Education Program of the American Society of Hematology, 2012, 522-528.
13. Chowdary, P., Saayman, A.G., Paulus, U., Findlay, G.P. & Collins, P.W. (2004) Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. British Journal of Haematology, 125, 69-73.
14. Chu, M.W.A., Wilson, S.R., Novick, R.J., Stitt, L.W. & Quantz, M.A. (2004) Does Clopidogrel increase blood loss following coronary artery bypass surgery. Annals of Thoracic Surgery, 78, 1536-1541.
15. Chung, J.H., Gikakis, N., Rao, A.K., Drake, T.A., Colman, R.W. & Edmunds, Jr, L.H. (1996) Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation, 93, 2014-2018.
16. Clark, K.B., Kon, N.D., Hammon, Jr, J.W., MacGregor, D.A., Kincaid, E.H. & Reichert, M.G. (2013) Factor IX complex for the treatment of severe bleeding after cardiac surgery. Journal of Cardiovascular Pharmacology, 62, 67-71.
17. Colomina, M.J., Díez Lobo, A., Garutti, I., Gómez-Luque, A., Llau, J.V. & Pita, E. (2012) Perioperative use of prothrombin complex concentrates. Minerva Anestesiologica, 78, 358-368.
18. Davies, G.C., Sobel, M. & Salzman, E.W. (1980) Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass. Circulation, 61, 808-814.
19. De Somer, F., Van Belleghem, Y., Caes, F., François, K., Van Overbeke, H., Arnout, J., Taeymans, Y. & Van Nooten, G. (2002) Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery, 123, 951-958.
20. Dhir, A. (2013) Antifibrinolytics in cardiac surgery. Annals of Cardiac Anaesthesia, 16, 117-125.
21. Dunning, J., Versteegh, M., Fabbri, A., Pavie, A., Kolh, P., Lockowandt, U. & Nashef, S.A.; EACTS Audit and Guidelines Committee. (2008) Guideline on antiplatelet and anticoagulation management in cardiac surgery. European Journal of Cardio-Thoracic Surgery, 34, 73-92.
22. Fergusson, D.A., Hébert, P.C., Mazer, C.D., Fremes, S., MacAdams, C., Murkin, J.M., Teoh, K., Duke, P.C., Arellano, R., Blajchman, M.A., Bussières, J.S., Côté, D., Karski, J., Martineau, R., Robblee, J.A., Rodger, M., Wells, G., Clinch, J. & Pretorius, R.; BART Investigators. (2008) A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. New England Journal of Medicine, 358, 2319-2331.
23. Ferraris, V.A., Ferraris, S.P., Reich, H., Rodriguez, E., Huang, M., Gupta, A., Bennett, J.A., Andersen, T.T. & Fenton, 2nd, J.W. (1996) Thrombin receptor related hemostatic defect after cardiopulmonary bypass. Seminars in Thrombosis and Hemostasis, 22, 351-356.
24. Ferraris, V.A., Brown, J.R., Despotis, G.J., Hammon, J.W., Reece, T.B., Saha, S.P., Song, H.K., Clough, E.R., Shore-Lesserson, L.J., Goodnough, L.T., Mazer, C.D., Shander, A., Stafford-Smith, M., Waters, J., Baker, R.A., Dickinson, T.A., FitzGerald, D.J., Likosky, D.S. & Shann, K.G. (2011) 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Annals of Thoracic Surgery, 91, 944-982.
25. Gelb, A.B., Roth, R.I., Levin, J., London, M.J., Noall, R.A., Hauck, W.W., Cloutier, M., Verrier, E. & Mangano, D.T. (1996) Changes in blood coagulation during and following cardiopulmonary bypass: lack of correlation with clinical bleeding. American Journal of Clinical Pathology, 106, 87-89.
26. Gill, R., Herbertson, M., Vuylsteke, A., Olsen, P.S., von Heymann, C., Mythen, M., Sellke, F., Booth, F. & Schmidt, T.A. (2009) Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation, 120, 21-27.
27. Gödje, O., Gallmeier, U., Schelian, M., Grünewald, M. & Mair, H. (2006) Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. The Thoracic and Cardiovascular Surgeon, 54, 26-33.
28. Golub, S., Ulin, A.W., Winchell, H.S., Ehrlich, E. & Weiss, W. (1959) Hemorrhagic diathesis associated with massive transfusion. Surgery, 45, 204-222.
29. Görlinger, K., Dirkmann, D., Hanke, A.A., Kamler, M., Kottenberg, E., Thielmann, M., Jakob, H. & Peters, J. (2011) First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology, 115, 1179-1191.
30. Gorman, R.C., Ziats, N., Rao, A.K., Gikakis, N., Sun, L., Khan, M.M., Stenach, N., Sapatnekar, S., Chouhan, V., Gorman, 3rd, J.H., Niewiarowski, S., Colman, R.W., Anderson, J.M. & Edmunds, Jr, L.H. (1996) Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass. Journal of Thoracic and Cardiovascular Surgery, 111, 1-11.
31. Gravlee, G.P., Arora, S., Lavender, S.W., Mills, S.A., Hudspeth, A.S., Cordell, A.R., James, R.L., Brockschmidt, J.K. & Stuart, J.J. (1994) Predictive value of blood clotting tests in cardiac surgical patients. Annals of Thoracic Surgery, 58, 216-221.
32. Guerrini, M., Beccati, D., Shriver, Z., Naggi, A., Viswanathan, K., Bisio, A., Capila, I., Lansing, J.C., Guglieri, S., Fraser, B., Al-Hakim, A., Gunay, N.S., Zhang, Z., Robinson, L., Buhse, L., Nasr, M., Woodcock, J., Langer, R., Venkataraman, G., Linhardt, R.J., Casu, B., Torri, G. & Sasisekharan, R. (2008) Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nature Biotechnology, 26, 669-675.
33. de Haan, J., Boonstra, P.W., Monnink, S.H., Ebels, T. & van Oeveren, W. (1995) Retransfusion of suctioned blood during cardiopulmonary bypass impairs hemostasis. Annals of Thoracic Surgery, 59, 901-907.
34. Harker, L.A., Malpass, T.W., Branson, H.E., Hessel, E.A. & Slichter, S.J. (1980) Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective α-granule release. Blood, 56, 824-834.
35. Hedlund, K.D., Coyne, D.P., Sanford, D.M. & Huddelson, J. (2013) The heparin recall of 2008. Perfusion, 28, 61-65.
36. Hunt, B.J., Parratt, R.N., Segal, H.C., Sheikh, S., Kallis, P. & Yacoub, M. (1998) Activation of coagulation and fibrinolysis during cardiothoracic operations. Annals of Thoracic Surgery, 65, 712-718.
37. Karkouti, K., von Heymann, C., Jespersen, C.M., Korte, W., Levy, J.H., Ranucci, M., Sellke, F.W. & Song, H.K. (2013) Efficacy and safety of recombinant factor XIII on reducing blood transfusions in cardiac surgery: a randomized, placebo-controlled, multicenter clinical trial. Journal of Thoracic and Cardiovascular Surgery, 146, 927-939.
38. Karlsson, M., Ternström, L., Hyllner, M., Baghaei, F., Flinck, A., Skrtic, S. & Jeppsson, A. (2009) Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thrombosis and Haemostasis, 102, 137-144.
39. Kind, S.L., Spahn-Nett, G.H., Emmert, M.Y., Eismon, J., Seifert, B., Spahn, D.R. & Theusinger, O.M. (2013) Is dilutional coagulopathy induced by different colloids reversible by replacement of fibrinogen and factor XIII concentrates? Anesthesia and Analgesia, 117, 1063-1071.
40. Kozek-Langenecker, S., Sørensen, B., Hess, J.R. & Spahn, D.R. (2011) Clinical effectiveness of fresh frozen plasma compared with fibrinogen concentrate: a systematic review. Critical Care, 15, R239.
41. Kuitunen, A.H., Hynynen, M.J., Vahtera, E. & Salmenperä, M.T. (2004) Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesthesia and Analgesia, 98, 291-297.
42. Levi, M., Fries, D., Gombotz, H., van der Linden, P., Nascimento, B., Callum, J.L., Bélisle, S., Rizoli, S., Hardy, J.F., Johansson, P.I., Samama, C.M., Grottke, O., Rossaint, R., Henny, C.P., Goslings, J.C., Theusinger, O.M., Spahn, D.R., Ganter, M.T., Hess, J.R., Dutton, R.P., Scalea, T.M., Levy, J.H., Spinella, P.C., Panzer, S. & Reesink, H.W. (2011) Prevention and treatment of coagulopathy in patients receiving massive transfusions. Vox Sanguinis, 101, 154-174.
43. Levy, J.H., Gill, R., Nussmeier, N.A., Olsen, P.S., Andersen, H.F., Booth, F.V. & Jespersen, C.M. (2009) Repletion of factor XIII following cardiopulmonary bypass using a recombinant A-subunit homodimer. Thrombosis and Haemostasis, 102, 765-771.
44. Lobato, R.L., Despotis, G.J., Levy, J.H., Shore-Lesserson, L.J., Carlson, M.O. & Bennett-Guerrero, E. (2010) Anticoagulation management during cardiopulmonary bypass: a survey of 54 North American institutions. Journal of Thoracic and Cardiovascular Surgery, 139, 1665-1666.
45. Mahla, E., Suarez, T.A., Bliden, K.P., Rehak, P., Metzler, H., Sequeira, A.J., Cho, P., Sell, J., Fan, J., Antonino, M.J., Tantry, U.S. & Gurbel, P.A. (2012) Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circulation. Cardiovascular Interventions, 5, 261-269.
46. Mammen, E.F., Koets, M.H., Washington, B.C., Wolk, L.W., Brown, J.M., Burdick, M., Selik, N.R. & Wilson, R.F. (1985) Hemostasis changes during cardiopulmonary bypass surgery. Seminars in Thrombosis and Hemostasis, 11, 281-292.
47. Marengo-Rowe, A.J., Lambert, C.J., Leveson, J.E., Thiele, J.P., Geisler, G.F., Adam, M. & Mitchel, B.F. (1979) The evaluation of hemorrhage in cardiac patients who have undergone extracorporeal circulation. Transfusion, 19, 426-433.
48. Masud, F., Bostan, F., Chi, E., Pass, S.E., Samir, H., Stuebing, K. & Liebl, M.G. (2009) Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes. Journal of Cardiothoracic and Vascular Anesthesia, 23, 28-33.
49. Miesbach, W. & Seifried, E. (2012) New direct oral anticoagulants-current therapeutic options and treatment recommendations for bleeding complications. Thrombosis and Haemostasis, 108, 625-632.
50. Nilsson, I.M. & Swedberg, J. (1959) Coagulation studies in cardiac surgery with extracorporeal circulation using a bubble-oxygenator. Acta Chirurgica Scandinavica, 117, 47-54.
51. Nuttall, G.A., Oliver, W.C., Ereth, M.H. & Santrach, P.J. (1997) Coagulation tests predict bleeding after cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia, 11, 815-823.
52. Ovrum, E., Brosstad, F., Am Holen, E., Tangen, G., Abdelnoor, M. & Oystese, R. (1996) Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis. European Journal of Cardio-Thoracic Surgery, 10, 449-455.
53. Philippou, H., Davidson, S.J., Mole, M.T., Pepper, J.R., Burman, J.F. & Lane, D.A. (1999) Two chain factor VIIa generated in the pericardium during surgery with cardiopulmonary bypass: relationship to increased thrombin generation and to heparin concentration. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 248-254.
54. Philippou, H., Adami, A., Davidson, S.J., Pepper, J.R., Burman, J.F. & Lane, D.A. (2000) Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass. Thrombosis and Haemostasis, 84, 124-128.
55. Rahe-Meyer, N., Pichlmaier, M., Haverich, A., Solomon, C., Winterhalter, M., Piepenbrock, S. & Tanaka, K.A. (2009a) Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. British Journal of Anaesthesia, 102, 785-792.
56. Rahe-Meyer, N., Solomon, C., Winterhalter, M., Piepenbrock, S., Tanaka, K., Haverich, A. & Pichlmaier, M. (2009b) Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery. Journal of Thoracic and Cardiovascular Surgery, 138, 694-702.
57. Ranucci, M., Aronson, S., Dietrich, W., Dyke, C.M., Hofmann, A., Karkouti, K., Levi, M., Murphy, G.J., Sellke, F.W., Shore-Lesserson, L. & von Heymann, C.; European Association of Cardiothoracic Anaesthesiologists. (2011) Patient blood management during cardiac surgery: do we have enough evidence for clinical practice? Journal of Thoracic and Cardiovascular Surgery, 142, 249.e1-32.
58. Ray, M.J., Marsh, N.A. & Hawson, G.A.T. (1994) Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass. Blood Coagulation & Fibrinolysis, 5, 679-685.
59. Rubens, F.D., Fergusson, D., Wells, P.S., Huang, M., McGowan, J.L. & Laupacis, A. (1998) Platelet-rich plasmapheresis in cardiac surgery: a meta-analysis of the effect on transfusion requirements. Journal of Thoracic and Cardiovascular Surgery, 116, 641-647.
60. Shuhaibar, M.N., Hargrove, M., Millat, M.H., O'Donnell, A. & Aherne, T. (2004) How much heparin do we really need to go on pump? A rethink of current practices. European Journal of Cardio-Thoracic Surgery, 26, 947-950.
61. Sørensen, B. & Bevan, D. (2010) A critical evaluation of cryoprecipitate for replacement of fibrinogen. British Journal of Haematology, 149, 834-843.
62. Spyropoulos, A.C. & Douketis, J.D. (2012) How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood, 120, 2954-2962.
63. Stibbe, J., Kluft, C., Brommer, E.J.P., Gomes, M., De Jong, D.S. & Nauta, J. (1984) Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasmingen activator. European Journal of Clinical Investigation, 14, 375-382.
64. Warkentin, T.E., Margetts, P., Connolly, S.J., Lamy, A., Ricci, C. & Eikelboom, J.W. (2012) Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. Blood, 119, 2172-2174.
65. Wikkelsø, A., Lunde, J., Johansen, M., Stensballe, J., Wetterslev, J., Møller, A.M. & Afshari, A. (2013) Fibrinogen concentrate in bleeding patients. Cochrane Database Systematic Review, CD008864.
66. Woodman, R.C. & Harker, L.A. (1990) Bleeding complications associated with cardiopulmonary bypass. Blood, 76, 1680-1697.
67. Yang, L., Vuylsteke, A., Gerrard, C., Besser, M. & Baglin, T. (2013) Postoperative fibrinogen level is associated with postoperative bleeding following cardiothoracic surgery and the effect of fibrinogen replacement therapy remains uncertain. Journal of Thrombosis and Haemostasis, 11, 1519-1526.